Insulin degludec - Novo Nordisk
At a glance
- Drug Originator Novo Nordisk
- Drug Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
- USA Patent Applicants NOVO
- USA Patents 29
- BLAs 1
- International Patents 436
Disclaimer